Virtual Pulmonary Rehab and Matched Care, With Omid Pourshahid, MD - HCPLive

At CHEST 2026, Pourshahid argued for matching patients to center-based, hybrid, or virtual pulmonary rehab based on a structured assessment. Arguing the pro side of a debate at the American College of Chest Physicians (CHEST) 2026 Annual Meeting in Phoenix, Omid Pourshahid, MD, MPH, FCCP, Medical Director, Pulmonary Rehabilitation, Temple University Hospital, said pulmonary rehabilitation should be tailored to each patient’s clinical status and barriers to care rather than delivered through a single center-based model.¹The position builds on a long-standing gap in pulmonary rehabilitation uptake. In a retrospective cohort of 197,376 Medicare beneficiaries hospitalized for COPD in 2014, only 2721 (1.5%) initiated pulmonary rehabilitation within 90 days of discharge.² Initiation within the 90-day window was associated with a lower risk of death at 1 year (hazard ratio [HR], 0.63; 95% CI, 0.57-0.69; P <.001).

Pulmonary fibrosis (PF) is a complex lung disease and falls under a larger group of lung diseases called interstitial lung disease (ILD). Genetics, certain medications and environmental exposures are some of the known causes of PF. Most often the cause is not known, which is referred to as idiopathic pulmonary fibrosis (IPF). In July 2025, the Lung Association, with support from the Feldman Family Foundation, launched the Pulmonary Fibrosis Lung Health Navigator program. The program provides participants with trusted lung disease education, personalized guidance and empowers participants to advocate for their lung health. To understand the impact of the free Lung Health Navigator program, we sat down with program participants to hear about their experience. We also spoke with Lung Health Navigators, Denise and Tiffany, who shared how the program helps those who call. Access Trusted InformationPeople living with PF have questions about their diagnosis, treatment options and what to expect as the disease progresses. Often, finding reliable information can be a challenge.

Google search results and OpenAI’s Responses API together found 26.2% of the pages ChatGPT cited in a preprint’s tests of the GPT-5.5 Instant setting. They found 48.7% of the sites behind those citations. Figures in this paper were posted on Oct. 11 by researchers at the National University of Singapore and Xi’an Jiaotong University. It included four versions of ChatGPT, from GPT-5.2 Instant to GPT-5.5 Instant, along with the majority of data collection from March 29 through July 29, 2026. The two stand-ins were able to be queried without having to open ChatGPT; the researchers compared both stand-ins’ results for similarity to the pages cited by ChatGPT’s web app.

Comedian Nate Bargatze dished on his early career at a conference. Nate Bargatze's first jobs weren't fancy. Pizza deliveryman, valet driver, mover — titles that "were always exactly what the job was," he said. "I remember going to one house, and they wanted me to go buy them beer," he recalled of his time working for Pizza Hut. "They'd give you a little extra cash, and you'd be like, 'Alright, that's nice.' A little extra $20 in the pocket, and you go. "Bargatze's career is now much more flashy. He's hosted SNL twice, starred in his own Netflix specials, headlined national tours, and is the leading man in Ford ad campaigns. And that's how Business Insider met Bargatze on Wednesday — at Ford's Accelerate conference. He emceed the Detroit event that brought together business leaders to talk about America's skilled-trades shortage. We asked Baratze about building a dream career. His response was remarkably similar to what CEOs at the conference were saying — but perhaps with less corporate frou-frou. Their main piece of advice: Don't expect your first role to be the dream job, and once you find an opening, make the most of it. A retail beginning?

Latent autoimmune diabetes in adults (LADA) may resemble type 2 diabetes mellitus (T2DM), creating diagnostic uncertainty and delaying appropriate treatment. This case illustrates the recognition of adult-onset autoimmune diabetes in an older, lean physician and the challenges surrounding the acceptance of insulin therapy. A 63-year-old male physician presented with an eight-week history of polyuria, polydipsia, nocturia, fatigue, reduced exercise tolerance and unintentional weight loss from approximately 62 kg to 53 kg. His body mass index had historically ranged from 19 to 22 kg/m², with no recognised features of metabolic syndrome. His brother reportedly had LADA. Initial investigations demonstrated a random plasma glucose of approximately 30 mmol/L and glycated haemoglobin (HbA1c) of 12.1% (108 mmol/mol). Glutamic acid decarboxylase antibodies were strongly positive (>110 U/mL), whereas islet antigen-2 antibodies were negative. Serum bicarbonate was normal, and renal function was preserved. C-peptide was not measured. Insulin was recommended at diagnosis because of severe symptomatic hyperglycaemia and marked catabolic weight loss. The patient initially declined injectable ther